Back to Screener

Simulations Plus, Inc. (SLP)

Price$14.97

Favorite Metrics

Price vs S&P 500 (26W)-9.87%
Price vs S&P 500 (4W)17.24%
Market Capitalization$295.00M
Indicated Dividend Yield (Annual)0.61%

All Metrics

P/CF (Annual)16.27x
Book Value / Share (Quarterly)$6.62
P/TBV (Annual)2.98x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)13.67%
Cash Flow / Share (Quarterly)$1.03
Payout Ratio (TTM)48.18%
Price vs S&P 500 (YTD)-21.81%
Gross Margin (TTM)61.97%
Net Profit Margin (TTM)-77.96%
EPS (TTM)$-3.12
10-Day Avg Trading Volume0.58M
EPS Excl Extra (TTM)$-3.12
Revenue Growth (5Y)13.74%
EPS (Annual)$-3.22
Dividend / Share (Annual)$0.00
ROI (Annual)-51.86%
Gross Margin (Annual)58.38%
Net Profit Margin (5Y Avg)-1.32%
Cash / Share (Quarterly)$2.07
Revenue Growth QoQ (YoY)8.29%
ROA (Last FY)-49.05%
Revenue Growth TTM (YoY)2.51%
EBITD / Share (TTM)$-3.01
ROE (5Y Avg)-5.53%
Operating Margin (TTM)-83.47%
Cash Flow / Share (Annual)$0.72
P/B Ratio2.21x
P/B Ratio (Quarterly)1.83x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)3.34x
Net Interest Coverage (TTM)570.50x
ROA (TTM)-45.61%
EPS Growth QoQ (YoY)47.76%
EV / EBITDA (TTM)18.98x
EPS Incl Extra (Annual)$-3.22
Current Ratio (Annual)7.67x
Quick Ratio (Quarterly)5.25x
3-Month Avg Trading Volume0.33M
52-Week Price Return-54.21%
EV / Free Cash Flow (Annual)18.70x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.23
P/S Ratio (Annual)3.73x
Asset Turnover (Annual)0.60x
52-Week High$36.45
Operating Margin (5Y Avg)-2.72%
EPS Excl Extra (Annual)$-3.22
CapEx CAGR (5Y)7.61%
Tangible BV CAGR (5Y)-6.11%
26-Week Price Return-2.98%
Quick Ratio (Annual)6.98x
13-Week Price Return-26.11%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.47x
Enterprise Value$269.273
Revenue / Share Growth (5Y)11.92%
Asset Turnover (TTM)0.59x
Book Value / Share Growth (5Y)-4.59%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)5.67x
Pretax Margin (Annual)-87.62%
Cash / Share (Annual)$1.61
3-Month Return Std Dev48.63%
Gross Margin (5Y Avg)71.52%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)10.94%
ROE (Last FY)-51.86%
Net Interest Coverage (Annual)70.00x
EPS Basic Excl Extra (Annual)$-3.22
P/FCF (TTM)14.21x
Receivables Turnover (TTM)3.59x
EV / Free Cash Flow (TTM)12.97x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-3.12
Receivables Turnover (Annual)5.34x
ROI (TTM)-49.30%
P/S Ratio (TTM)3.66x
Pretax Margin (5Y Avg)0.33%
Revenue / Share (Annual)$3.94
Tangible BV / Share (Annual)$4.75
Forward P/E16.79x
Free OCF CAGR (5Y)11.57%
Price vs S&P 500 (52W)-88.84%
Year-to-Date Return-17.88%
5-Day Price Return11.97%
EPS Normalized (Annual)$-3.22
ROA (5Y Avg)-5.32%
Net Profit Margin (Annual)-81.74%
Month-to-Date Return26.65%
Cash Flow / Share (TTM)$0.67
EBITD / Share (Annual)$-3.08
Operating Margin (Annual)-88.52%
P/CF (TTM)12.10x
ROI (5Y Avg)-5.53%
EPS Basic Excl Extra (TTM)$-3.12
P/TBV (Quarterly)2.31x
Payout Ratio (Annual)48.18%
P/B Ratio (Annual)2.29x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)4.45x
Pretax Margin (TTM)-82.32%
Book Value / Share (Annual)$6.20
Price vs S&P 500 (13W)-28.49%
Dividend Yield (TTM)0.00%
Beta1.32x
P/FCF (Annual)20.48x
Revenue / Share (TTM)$3.98
ROE (TTM)-49.30%
52-Week Low$11.09

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
3.82
3.82
3.82

Industry Peers — Computer Integrated Systems(35)

SymbolP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)Operating Margin (TTM)Price
SLPSimulations Plus, Inc.
3.66x2.51%61.97%-83.47%$14.97
LDOSLeidos Holdings, Inc.
1.15x3.07%18.04%12.28%$154.82
IOTSamsara Inc.
10.99x29.57%76.74%-3.25%$30.81
IONQ.WSIonQ, Inc. Redeemable warrants, each whole warrant exercisable for one share of Common Stock, each at an exercise price of $11.50 per share
136.26x201.85%42.06%-487.41%$36.66
IONQIonQ, Inc.
129.97x201.85%42.06%-487.41%$48.32
GDDYGoDaddy Inc
2.36x8.26%63.61%22.80%$87.61
CACICACI INTERNATIONAL CLA
1.29x10.41%32.50%9.15%$522.07
JKHYHenry (Jack) & Associates
4.50x8.41%43.84%25.87%$153.87
AURAurora Innovation, Inc. Class A Common Stock
3444.24x-23000.00%$5.22
OTEXOpen Text Corp
1.14x-4.30%72.70%18.39%$23.36
PSNParsons Corporation
0.94x-5.72%22.49%6.57%$54.92

About

Simulations Plus develops software for pharmaceutical research and drug development, with its flagship ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling platform serving a core use case in early-stage drug testing. The company generates revenue primarily through software sales, supplemented by consulting and contract research services for pharmaceutical clients. Geographic revenue is concentrated in the United States, with secondary markets in EMEA and Asia Pacific.